Combined Impact of Polymorphism of Folate Metabolism Genes; Glutamate Carboxypeptidase,
Abstract
Background: Folate and methionine play a crucial role in DNA synthesis, repair and the epigenetic prole of cell. Hence, the
alterations in the folate metabolism can lead to aberrant proliferation leading to neoplasia. Most of the studies have associated
polymorphisms in methylene tetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) genes with
reduced risk of cervical and colorectal cancer. However, the association with breast cancer is still controversial. Further, the
involvement of Glutamate carboxypeptidase II (GCPII) polymorphism in cancer is not known. In the present study, we analyzed if
the individual and combined effects of polymorphisms in folate pathway genes viz., MTHFR 677C > T, MTHFR 1298A > C, MTRR
66A > G and GCP II 1561 C>T, have any role in altering the susceptibility to breast cancer.
Methods: The DNA of 35 female breast cancer patients and 33 healthy individuals, in the Kashmiri population from India, were
analyzed using a PCR-RFLP approach for the above mentioned polymorphisms.
Results: Individuals carrying the MTHFR 677CT/TT and GCPII 1561 CT genotype showed a 3.5 (95% CI: 3.1-3.7, P<0.02) and
7.7 (95% CI: 6.7-9.1, P<0.001) fold decreased risk for breast cancer than the wild types (MTHFR 677CC and GCPII 1561 CC).
Subjects with MTRR 66 G-allele showed a 4.5 fold decreased risk (OR: 0.22, 95% CI: 0.20, 0.24, P<0.0005) compared to the
wild type (MTRR 66A). Further, subjects with combined polymorphisms in MTHFR, GCPII and MTRR loci revealed a signicant
reduction of breast cancer risk.
Conclusion: This study indicates (i) a protective role of polymorphisms in MTHFR, GCPII, MTRR against breast cancer in
the study subjects, and (ii) combined effect of polymorphisms is more pronounced than single genetic polymorphism, thereby
emphasizing the role of gene-gene interaction in the susceptibility to breast cancer.
alterations in the folate metabolism can lead to aberrant proliferation leading to neoplasia. Most of the studies have associated
polymorphisms in methylene tetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) genes with
reduced risk of cervical and colorectal cancer. However, the association with breast cancer is still controversial. Further, the
involvement of Glutamate carboxypeptidase II (GCPII) polymorphism in cancer is not known. In the present study, we analyzed if
the individual and combined effects of polymorphisms in folate pathway genes viz., MTHFR 677C > T, MTHFR 1298A > C, MTRR
66A > G and GCP II 1561 C>T, have any role in altering the susceptibility to breast cancer.
Methods: The DNA of 35 female breast cancer patients and 33 healthy individuals, in the Kashmiri population from India, were
analyzed using a PCR-RFLP approach for the above mentioned polymorphisms.
Results: Individuals carrying the MTHFR 677CT/TT and GCPII 1561 CT genotype showed a 3.5 (95% CI: 3.1-3.7, P<0.02) and
7.7 (95% CI: 6.7-9.1, P<0.001) fold decreased risk for breast cancer than the wild types (MTHFR 677CC and GCPII 1561 CC).
Subjects with MTRR 66 G-allele showed a 4.5 fold decreased risk (OR: 0.22, 95% CI: 0.20, 0.24, P<0.0005) compared to the
wild type (MTRR 66A). Further, subjects with combined polymorphisms in MTHFR, GCPII and MTRR loci revealed a signicant
reduction of breast cancer risk.
Conclusion: This study indicates (i) a protective role of polymorphisms in MTHFR, GCPII, MTRR against breast cancer in
the study subjects, and (ii) combined effect of polymorphisms is more pronounced than single genetic polymorphism, thereby
emphasizing the role of gene-gene interaction in the susceptibility to breast cancer.
Muzaffar, M. M., Dar, J. A., Dar, N. A., Dar, S. M., Salam, I., Lone, M. M., & Chowdary, N. A. (2008). Combined Impact of Polymorphism of Folate Metabolism Genes; Glutamate Carboxypeptidase,. International Journal of Health Sciences, 2(1). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/63
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Copyright and license info is not available